FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011647595> ?p ?o ?g. }

• W2011647595 endingPage "768" @default.
• W2011647595 startingPage "756" @default.
• W2011647595 abstract "Reactive oxygen species (ROS) play an important role in the pathogenesis of airway inflammation and hyperresponsiveness. Recent studies have demonstrated that antioxidants are able to reduce airway inflammation and hyperreactivity in animal models of allergic airway disease. A newly developed antioxidant, small molecular weight thiol compound, N-acetylcysteine amide (AD4) has been shown to increase cellular levels of glutathione and to attenuate oxidative stress related disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. However, the effects of AD4 on allergic airway disease such as asthma are unknown. We used ovalbumin (OVA)-inhaled mice to evaluate the role of AD4 in allergic airway disease. In this study with OVA-inhaled mice, the increased ROS generation, the increased levels of Th2 cytokines and VEGF, the increased vascular permeability, the increased mucus production, and the increased airway resistance in the lungs were significantly reduced by the administration of AD4. We also found that the administration of AD4 decreased the increases of the NF-kappaB and hypoxia-inducible factor-1alpha (HIF-1alpha) levels in nuclear protein extracts of lung tissues after OVA inhalation. These results suggest that AD4 attenuates airway inflammation and hyperresponsiveness by regulating activation of NF-kappaB and HIF-1alpha as well as reducing ROS generation in allergic airway disease." @default.
• W2011647595 created "2016-06-24" @default.
• W2011647595 creator A5005276113 @default.
• W2011647595 creator A5006396753 @default.
• W2011647595 creator A5014274725 @default.
• W2011647595 creator A5015188655 @default.
• W2011647595 creator A5020988404 @default.
• W2011647595 creator A5032371779 @default.
• W2011647595 creator A5052588819 @default.
• W2011647595 creator A5053340200 @default.
• W2011647595 creator A5057454247 @default.
• W2011647595 creator A5073854525 @default.
• W2011647595 creator A5084700001 @default.
• W2011647595 creator A5084778751 @default.
• W2011647595 creator A5090545099 @default.
• W2011647595 date "2007-12-01" @default.
• W2011647595 modified "2023-10-16" @default.
• W2011647595 title "A novel thiol compound, N-acetylcysteine amide, attenuates allergic airway disease by regulating activation of NF-κB and hypoxia-inducible factor-1α" @default.
• W2011647595 cites W142971503 @default.
• W2011647595 cites W1480915911 @default.
• W2011647595 cites W1494867744 @default.
• W2011647595 cites W1547863599 @default.
• W2011647595 cites W1598900543 @default.
• W2011647595 cites W1921504045 @default.
• W2011647595 cites W1963575320 @default.
• W2011647595 cites W1966266255 @default.
• W2011647595 cites W1978012368 @default.
• W2011647595 cites W1984454286 @default.
• W2011647595 cites W1985286895 @default.
• W2011647595 cites W2008061906 @default.
• W2011647595 cites W2011007912 @default.
• W2011647595 cites W2011575208 @default.
• W2011647595 cites W2014569228 @default.
• W2011647595 cites W2014765226 @default.
• W2011647595 cites W2016523675 @default.
• W2011647595 cites W2024206845 @default.
• W2011647595 cites W2026121960 @default.
• W2011647595 cites W2032742683 @default.
• W2011647595 cites W2034745562 @default.
• W2011647595 cites W2040031153 @default.
• W2011647595 cites W2040470926 @default.
• W2011647595 cites W2043433914 @default.
• W2011647595 cites W2048443173 @default.
• W2011647595 cites W2060763719 @default.
• W2011647595 cites W2063875296 @default.
• W2011647595 cites W2064222371 @default.
• W2011647595 cites W2065068592 @default.
• W2011647595 cites W2072129394 @default.
• W2011647595 cites W2081463612 @default.
• W2011647595 cites W2083087446 @default.
• W2011647595 cites W2088246788 @default.
• W2011647595 cites W2089312586 @default.
• W2011647595 cites W2092890519 @default.
• W2011647595 cites W2100662719 @default.
• W2011647595 cites W2102526923 @default.
• W2011647595 cites W2107410714 @default.
• W2011647595 cites W2107721620 @default.
• W2011647595 cites W2114287617 @default.
• W2011647595 cites W2117934143 @default.
• W2011647595 cites W2119267064 @default.
• W2011647595 cites W2121464855 @default.
• W2011647595 cites W2124714277 @default.
• W2011647595 cites W2127203245 @default.
• W2011647595 cites W2140942460 @default.
• W2011647595 cites W2141907963 @default.
• W2011647595 cites W2142541950 @default.
• W2011647595 cites W2143352735 @default.
• W2011647595 cites W2152059658 @default.
• W2011647595 cites W2154899903 @default.
• W2011647595 cites W2161528133 @default.
• W2011647595 cites W2165523086 @default.
• W2011647595 cites W2166781237 @default.
• W2011647595 cites W2166982073 @default.
• W2011647595 cites W2306418883 @default.
• W2011647595 cites W2331176038 @default.
• W2011647595 cites W2409176673 @default.
• W2011647595 cites W2415512355 @default.
• W2011647595 cites W250211167 @default.
• W2011647595 cites W32167704 @default.
• W2011647595 cites W2071607630 @default.
• W2011647595 doi "https://doi.org/10.1038/emm.2007.82" @default.
• W2011647595 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18160846" @default.
• W2011647595 hasPublicationYear "2007" @default.
• W2011647595 type Work @default.
• W2011647595 sameAs 2011647595 @default.
• W2011647595 citedByCount "74" @default.
• W2011647595 countsByYear W20116475952012 @default.
• W2011647595 countsByYear W20116475952013 @default.
• W2011647595 countsByYear W20116475952014 @default.
• W2011647595 countsByYear W20116475952015 @default.
• W2011647595 countsByYear W20116475952016 @default.
• W2011647595 countsByYear W20116475952017 @default.
• W2011647595 countsByYear W20116475952018 @default.
• W2011647595 countsByYear W20116475952019 @default.
• W2011647595 countsByYear W20116475952020 @default.
• W2011647595 countsByYear W20116475952021 @default.
• W2011647595 countsByYear W20116475952022 @default.
• W2011647595 crossrefType "journal-article" @default.

• next